ADEKUNBI OBISESAN: Open Payments
NPI 1144765132 · SUGAR LAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$644 in 32 payments from 8 companies in 2025. Trend: 2023 $399 · 2024 $317 · 2025 $644
Food & beverage: $644
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $221 |
| Lilly USA, LLC | 8 | $136 |
| AstraZeneca Pharmaceuticals LP | 3 | $120 |
| GlaxoSmithKline, LLC. | 4 | $75 |
| Amgen Inc. | 3 | $47 |
| Exact Sciences Corporation | 1 | $16 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
| IBSA Pharma Inc. | 1 | $14 |
Products named: MOUNJARO, SAPHNELO, Wegovy, SHINGRIX, Ozempic, REPATHA, AIRSUPRA, TALTZ.
Industry payments across TX — which companies pay providers there.
